Undervalued Stocks Based On Cash Flows

Resultados

144

12 nuevo

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

144 empresas

EmpresaÚltimo precio7D RetornoRendimiento 1 añoCapitalización bursátilObjetivo de los analistasValoraciónCrecimientoDiv RendimientoIndustria
MWH
US$28.92-11.6%n/aUS$6.1bUS$45.1830.021.4%n/aCapital Goods
HBAN
US$17.01-5.0%-2.0%US$34.4bUS$20.301.225.7%3.6%Banks
CBRS
US$209.85-4.2%n/aUS$49.9bUS$291.6473.2119.6%n/aSemiconductors
ALRS
US$32.59-3.2%45.0%US$811.6mUS$35.4029.440.6%2.7%Diversified Financials
SYM
US$41.46-0.8%-5.6%US$25.4bUS$64.32655.955.5%n/aCapital Goods
GSHD
Nuevo
US$70.706.7%-21.0%US$2.5bUS$68.9247.720.4%0%Insurance
SPT
US$10.071.0%-32.3%US$607.7mUS$10.441.3107.1%n/aSoftware
ZETA
US$27.85-6.0%52.3%US$7.2bUS$31.364.549.1%n/aSoftware
YOU
US$42.90-6.1%23.6%US$6.0bUS$62.6029.922.0%1.9%Software
WLTH
US$9.16-3.1%n/aUS$1.4bUS$12.253.785.4%n/aDiversified Financials
J
US$147.942.8%0.4%US$17.2bUS$162.5348.228.7%1.0%Commercial Services
XERS
US$8.603.2%13.3%US$1.6bUS$11.714.755.9%n/aPharmaceuticals & Biotech
NTRA
US$324.844.5%100.6%US$46.9bUS$336.7417.362.6%n/aPharmaceuticals & Biotech
HTB
Nuevo
US$46.71-6.8%18.4%US$779.1mUS$54.751.325.6%1.3%Banks
GPC
US$132.92-1.8%-2.5%US$18.5bUS$140.38559.241.7%3.2%Retail
MBLY
US$8.88-0.2%-36.1%US$7.7bUS$12.113.794.2%n/aAutomobiles
BA
US$215.10-6.6%-4.2%US$175.6bUS$274.8581.442.9%0%Capital Goods
FLEX
US$110.32-12.6%112.5%US$40.8bUS$160.5041.944.9%n/aTech
MELI
US$1,921.964.2%-20.9%US$97.5bUS$2,256.5452.329.0%0%Retail
COHR
US$290.03-11.4%234.9%US$56.3bUS$416.0973.843.9%n/aTech
RHI
US$43.880.2%22.0%US$4.4bUS$35.0038.531.8%5.4%Commercial Services
FORM
US$115.71-12.1%296.8%US$9.0bUS$138.6378.343.7%n/aSemiconductors
VSXY
US$86.80-4.7%306.7%US$7.0bUS$93.6032.746.0%n/aRetail
BE
US$202.48-14.3%351.7%US$60.9bUS$275.08243.542.5%n/aCapital Goods
Page 1 of 4